Confidential IPV Screening Tool

Not Applicable

Completed

• Conditions: Violence, Domestic

• Registration Number: NCT06284148
• Lead Sponsor: Medical University of South Carolina

Brief Summary

Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.

Detailed Description

The objective of this study was to develop and evaluate an integrated suite of electronic health record (EHR) tools that automates "best practices" from Northern California Kaiser Permanente for screening and intervention for IPV identified within clinical settings. The goal of the intervention goes beyond mere screening of patients for IPV and includes tools for assessment of IPV risk, for documentation of IPV care, and support for a warm hand-off during the primary care visit to a national IPV hotline resource. Importantly, the study includes work to keep notes documenting IPV and billing for IPV care confidential, segmenting this care in a secure segment of the electronic health record.

Study Timeline

• Study Start: 2010-10-06
• Primary Completion: 2023-07-31
• Study Completion: 2023-07-31
• Status Verified: 2024-02
• Study First Submitted: 2024-02-09
• Study First Submitted QC: 2024-02-21
• Last Update Submitted: 2024-02-21
• Study First Posted: 2024-02-28
• Last Update Posted: 2024-02-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 19655

Inclusion Criteria

• Being an Medical University of South Carolina patient at primary care clinics (family medicine)
• Women 18-49 years of age inclusive
• Reported yes to wanting to be contacted for a follow-up research study
• English-speaking

Exclusion Criteria

• No exclusion criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SEQUENTIAL

Primary Outcome Measures

Name	Time	Method
IPV positive (Yes/No)	29 months	Depending on patient's answers to screening questions, they are flagged as either IPV positive or negative
Screening completed (Yes/No)	29 months	Whether the assigned screening was completed during patient visit

Secondary Outcome Measures

Name	Time	Method
Physician compliance with IPV management tools	29 months	Measured as the rate of completion of follow-up decision templates, and the rate of referrals for post-visit counseling to a national hotline (a share from screened positive patients
Severity of risk	29 months	using Danger 5 risk assessment, ranging from 0 to 5

Trial Locations

Locations (1)

Biomedical Informatics Center; 🇺🇸 Charleston, South Carolina, United States